Products
Online Inquiry
GSK-3 Inhibitor 5
Cat. No.:
OB0225WX-2156
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
GSK-3 Inhibitor 5 is a phenacyl bromide derivative that functions as a pharmaceutical intermediate and an inhibitor of glycogen synthase kinase 3 (GSK-3).
Synonym:
4-Cyanophenacyl bromide; 20099-89-2; 4-(2-bromoacetyl)benzonitrile; 4-Cyanophenacyl bromide; 4-(Bromoacetyl)benzonitrile; 2-Bromo-4'-cyanoacetophenone; Benzonitrile, 4-(bromoacetyl)-; p-Cyanophenacyl bromide; Benzonitrile, 4-(2-bromoacetyl)-; 4-(2-bromo-acetyl)-benzonitrile; MFCD00052931; p-Bromoacetylbenzonitrile; 4-bromoacetylbenzonitrile; 4-bromoacetyl benzonitrile; 4-Bromoacetyl-benzonitrile; 2-bromo-4'-cyano acetophenone; 2-bromo-4'-cyano-acetophenone; 4-(2-bromoacetyl)-benzonitrile
CAS No.:
20099-89-2
Compound CID:
98654
Formula:
C9H6BrN
Formula Weight:
224.05
Specification
Relative Density:
1.56 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GSK-3 Inhibitor 5 is employed in laboratory experiments to characterize the structural binding affinity of small molecules to the GSK-3 active site and the resulting modulation of glycogen synthase activity.
Library Information
Target:
GSK-3
Receptor:
GSK-3
Pathways:
Stem cells; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-28
Plate Location:
e11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 245.48 mM
